Dynamic jaw delivery on the TomoTherapy H‐series platform, entitled TomoEDGE™, is an effective tool to decrease the patient dose along the superior and inferior edges of the treatment target. The aperture of the TomoTherapy jaws, that is, field width (FW), defines the longitudinal dose profile. A consistent FW dose profile is an important quantity for accurate and reproducible dose delivery in TomoTherapy. To date, no evaluation has been made of the accuracy and precision of the dose profiles produced by dynamic jaws. This study aims to provide a long‐term evaluation of the dynamic jaw FW dose profiles obtained on TomoTherapy utilizing the TomoTherapy Quality Assurance procedure (TQA). A total of 840 dose profiles were measured during 84 TQA procedures, performed over a 2‐yr period. The full width at half maximum (FWHM) and constancy of the FW dose profile measurements were analyzed and compared with the tolerances proposed by AAPM Task Group 148 (TG‐148) and those used by the manufacturer. The FWHM evaluation showed that the FWs > 2.0 cm respect the TG‐148 tolerance of 1%, while the asymmetric FWs ≤ 2.0 cm were outside the limit in 17.3% of measurements. Constancy results evaluated along the full profiles showed that 95.2% of measurements were within 3% of the baseline for symmetric FWs and 94.8% of measurements were within 4% of the baseline for asymmetric FWs. In conclusion, the analysis confirms the accuracy and precision of TomoEDGE™ technology in jaw positioning. This study has identified the potential to establish an appropriate QA tolerance for the asymmetric FWs used in dynamic jaw movement. Finally, the clinical significance of the observed discrepancies should be studied further to understand the dosimetric effect on patient treatments.